Theresa Greco
Equibles does not estimate personal net worth.
About Theresa Greco
OptimizeRx Corp reported in an 8-K filed June 5, 2026 that Theresa Greco resigned as Chief Commercial Officer, effective June 15, 2026. The proxy statement of OptimizeRx Corp reports total compensation of $1,544,265 for Theresa Greco in fiscal 2025, including a base salary of $367,500.
“OptimizeRx Corporation (the “Company”) and Theresa Greco agreed on May 11, 2026 to a separation, effective as of June 15, 2026 (the “Separation Date”).”
Affiliation history
-
OptimizeRx Corp (OPRX)
Proxy statement
Start not stated–2026-06-15
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | OptimizeRx Corp (OPRX) | Chief Commercial Officer | $367,500 | $1,544,265 |